Think

Search This Blog

Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

August 07, 2025

Get link
Facebook
X
Pinterest
Email
Other Apps

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

Gina Kolata | NYTimes Health | Disclosure

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

Female Cardiothoracic Surgeons, Unlocking the Male Fortress

Less than 10 percent of heart and lung surgeons in the United States are women. At a recent conference, they vowed to change that. Elisabeth Bumiller and Alyssa Schukar | NYTimes Health | Disclosure

Wheelchair? Hearing Aids? Yes. ‘Disabled’? No Way.

Many older Americans shun an identity that could bring helpful accommodations, improve care and provide community. Paula Span | NYTimes Health | Disclosure

New Gene-Editing Strategy Could Help Development of Treatments for Rare Diseases

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. Pam Belluck and Carl Zimmer | NYTimes Health | Disclosure

F.D.A. Will Remove Black Box Warnings From Hormone Treatments for Menopause

The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient. Roni Caryn Rabin | NYTimes Health | Disclosure

She’s on a Mission to Make the World More Bike-Friendly

Melissa Bruntlett advocates equitable, inclusive and sustainable mobility — and writes about other women who do, too. Tanya Mohn | NYTimes Health | Disclosure

Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

Comments

Post a Comment